VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor
US12065486B2 · kind B2 · utility
0Cited by
34References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 2, 2021 |
| Grant date | Aug 20, 2024 |
| Priority date | — |
| Expiry date | Jan 28, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/954
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods, compositions and kits are provided for treating a subject exposed to or at risk for exposure to a disease agent, methods, compositions and kits having a pharmaceutical composition including at least one recombinant binding protein or a source of expression of the binding protein, wherein the binding protein neutralizes at least one or a plurality of disease agents that are toxins, for example at least one of a Botulinum toxin or an Anthrax toxin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.